Company: G
Filing Date: 2025-08-11
Form Type: 10-Q
Source: 0001398659-25-000098
Chunk: 128

Company: Genpact LTD
Filing Date: 2025-08-11
Form: 10-Q
Item: Part II, Item 5
Chunk 128
---
Item 5. Other Information

(c) Director and Officer Trading Arrangements

The following table describes, for the quarterly period covered by this report, each trading arrangement for the sale or purchase of our securities adopted or terminated by our directors and officers that is either (1) a contract, instruction or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) (a “Rule 10b5-1 trading arrangement”) or (2) a “non-Rule 10b5-1 trading arrangement” (as defined in Item 408(c) of Regulation S-K):Name (Title)Action Taken (Date of Action)Type of Trading ArrangementNature of Trading ArrangementDuration of Trading ArrangementAggregate Number of SecuritiesBalkrishan Kalra (President and CEO)Termination (June 11, 2025)Rule 10b5-1 trading arrangementSale of common shares acquired upon exercise of vested optionsUntil September 30, 2025, or such earlier date upon which all transactions are completedUp to 54,400 common shares issuable upon the exercise of vested options

70